Navigation Links
White Smile Global Inc. (WSML) Names Dr. Martin S. Giniger, D.M.D., Ph.D., MsD, FICD New Scientific Director Bringing Decades of Proven Scientific Advancements to Create the All New White Smile™ Organic Product Line

MIAMI, Oct. 17, 2011 /PRNewswire/ -- White Smile Global Inc. (OTCBB: WSML) has announced the appointment of Dr. Martin S. Giniger, D.M.D., PhD, MsD, FICD, as Chief Science Officer, and Director of Oral Health Research. Dr. Giniger will direct White Smile Global Inc.'s research and development team, based in Miami Beach, Florida, which includes many novel consumer and professional dental products including a line of natural healthy foaming oral health innovations, including a new patent-pending oral foam, that uses the power of effervescing oxidizers to whiten teeth, thus replacing traditional tooth "pastes" for daily use.

"Dr. Giniger is without question the world's most highly recognized scientist of international repute in the areas oral health product development and teeth whitening formulations," states White Smile Global CEO Mr. Omar Ahmadzai. "Dr. Giniger has been responsible for some of the biggest name products and most widely distributed brands throughout the world, and his scientific direction will further the progress of our goal in becoming the leading innovator in the over-the-counter, consumer friendly 'All-Natural' dental products," he added.

Dr. Martin Giniger has dedicated his professional and scientific career to oral care product development and clinical testing of toothpaste, mouthwash, toothbrushes, vital tooth bleaching preparations and other oral care and personal care products.

Prior to joining White Smile Global as Chief Scientific Officer, Dr. Giniger's education and training includes specialty certificate in Oral Medicine and Oral Pathology and a Ph.D. in Biochemistry (during which he discovered a new way in which melanoma cell spread using the basement membrane glycoprotein, Laminin, as a signaling molecule) from the University of Connecticut.  There he also was recipient of an NIH Physician-Scientist Award and other scientific grants and was also the recipient of the Loeser Award from the Academy of Oral Medicine for excellence in that sub-specialty of dentistry. Furthermore, he received his DMD degree from Fairleigh Dickinson College of Dental Medicine and was given the Basic Sciences Award at graduation.

His academic positions have included Assistant Professor of Physiology at the Louisiana State University School of Medicine, Assistant Professor of Oral Medicine at the Louisiana State University School of Dental Medicine, Director of the Medical Blood Chemistry Laboratory at Louisiana State University School of Dental Medicine, Clinical Scholar at the University of Connecticut, Director of the Division of Diagnostic Sciences at the University of Medicine and Dentistry of New Jersey and Director of the Department of Community Services at UMDNJ (New Jersey Dental School).  

Furthermore, Dr. Giniger has 18 years of experience working for oral care companies and 25 years working as a dentist. Dr. Giniger is the world's most knowledgeable expert on the subject of OTC dental products formulation and knows the insider secrets that no one else in the world could know. He has a special interest in "liquid" and "effervescent foaming" oral care products and has published several manuscripts relating to this topic. He has worked full time for many consumer marketing, oral care and dental products companies. Of note, he served the Colgate-Palmolive Company, the world's largest consumer oral care company, as Director of Professional and Academic Marketing and later as Head of Clinical Research. He has also worked full-time for Dexcel Pharma (VP of Clinical research) and Smile Paradigm Inc (Founder and CEO - mostly working on Discus Dental projects (Zoom!™). He has also consulted on a part-time basis for just about every major oral care company on earth including: Colgate-Palmolive, Procter & Gamble, Church & Dwight, BriteSmile, Discus Dental and many others. Over the years Dr. Giniger has helped to develop many new oral care and dental products for commercial sale and they have sold more than $10 billion dollars in aggregate for the companies he developed them for. The top selling products which he played a role in are: Colgate Total Toothpaste, Colgate Platinum Tooth Whitening System, Colgate Simply White, Colgate Liquid Total Toothpaste, Discus Dental Nite White with ACP, Discus Dental Zoom 2 and Dexcel Pharma Periochip R.

White Smile Global Inc. (OTCBB: WSML) is a fully reporting publicly traded Company on the OTC Bulletin Board.  The Company is headquartered in South Beach Miami, Florida on the famous Lincoln Road.

To schedule an interview with Dr. Giniger or to obtain further information on White Smile™ products or Corporate information, call White Smile Global Inc. Office at 1.888.WSMILE1 or email at Web home page at

For more information please contact:

White Smile Global Inc.
Toll Free: 1.888.WSMILE1

General Information:


This announcement is not an offer to sell any White Smile Global  ("WSML") or related securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of WSML may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and includes, without limitation, statements regarding WSML's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors beyond our control that could cause actual events or results to be significantly different from those described in the forward-looking statements. Any or all of our forward-looking statements in this report or in any other public statements we make may turn out to be wrong. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise.

SOURCE White Smile Global Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
3. White Nose Syndrome: Is Pennsylvania Next?
4. White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
5. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
6. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
7. BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes Quality Equals Defensibility
8. Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services
9. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
10. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
11. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/25/2015)... 25, 2015 ... the "Global Brain Monitoring Devices Market ... --> ) has announced the ... Devices Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/25/2015)... N.C. , Nov. 25, 2015 ... the planned investment of at least $15.8  Million ... Wilmington, NC . The expansion ... capacity to meet the growing demands of the ... site expansion will provide up to ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge Memorial ... in the Waterloo region. Using the Ocean Platform, family physicians can now order ... electronic medical record (EMR) without the need for redundant patient entry or an ...
(Date:11/26/2015)... ... , ... The Catalent Applied Drug Delivery Institute today announced ... form selection in early phase drug development. The first of these is to ... the UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, ...
(Date:11/26/2015)... ... 26, 2015 , ... PRMA Plastic Surgery is updating their record books yet ... 6,000th free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, ... lives and it’s an honor to have served all of these women.” , PRMA ...
(Date:11/26/2015)... Viejo, CA (PRWEB) , ... November 26, 2015 ... ... users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This ... style options. These classically-influenced trailer titles work with any font, giving users limitless ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
Breaking Medicine News(10 mins):